Mycotoxins as Causal Factors of Diseases in Humans

References

• Smith J. E., Henderson R. S. Mycotoxins and Animal Foods. CRC Press, Boston 1991
   Google Scholar
• Miller J. D., Trenholm H. L. Mycotoxins in Grain; Compounds other than aflatoxin. Eagan Press, St. Paul, Mnnesota 1994
   Google Scholar
• Hsieh D. P.H. Health risks posed by mycotoxins in foods. Korean J. Toxicol. 1990; 6(2)159–166
   Google Scholar
• Steyn P. S., Stander M. A. Mycotoxins with special reference to rhe carcinogenic mycotoxins: aflatoxins, ochratoxins and fumonisins. General and Applied Toxicology2nd edition. 1989, in press
   Google Scholar
• van Egmond H. P., Speijers G. J.A. Survey of data on the incidence and levels of ochratoxin A in food and animal feed worldwide. Journal of Natural Toxins 1994; 3(2)125–143
   Google Scholar
• van Rensburg S. J. Role of mycotoxins in endemic liver and oesophageal cancer. Mycotoxins and phycotoxins, P. S. Steyn, R. Vleggaar. Elsevier, Amsterdam 1989; 483–494
   Google Scholar
• Wang L-Y., Hatch M., Chen C-J., Levin B., You S-L., Lu S-N., Wu M-H., Wu W-P., Wang L-W., Wang Q., Huang G-Y., Yang P-M., Lee H-S., Santella R. M. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. International Journal of Cancer 1996; 67(5)620–625
   PubMed Web of Science ®Google Scholar
• Ishii K., Maeda K., Kamataki T., Kato R. Mutagenic activation of aflatoxin B1by several forms of purified cytochrome P450. Mutat. Res. 1986; 174: 85–88
   PubMed Web of Science ®Google Scholar
• Forrester L. M., Neal G. E., Judah D. J., Glancey M. J., Wolf C. R. Evidence for involvement of multiple forms of cytochrome P450 in aflatoxin B1metabolism in human liver. Proc. Natl. Acad. Sci. USA 1990; 87: 8306–8310
   PubMed Web of Science ®Google Scholar
• Raney K. D., Coles B., Guengrich F. P., Harris T. M. The errdo-8,9-epoxide of aflatoxin B1: a new metabolite. Chem. Res. Toxicol. 1992; 5: 333–335
   PubMed Web of Science ®Google Scholar
• Iyer R. S., Coles B. F., Thier K. D., Guengerich F. P., Harris T. M. DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies. J. Am. Chem. Soc. 1994; 116: 1603–1609
   Web of Science ®Google Scholar
• Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr, Reinhold V. N., Büchi G., Wogan G. N. Structural identification of the major DNA adduct formed bv aflatoxin B1in vitro. Proc. Natl. Acad. Sci. USA 1977; 74: 1870–1874
   PubMed Web of Science ®Google Scholar
• Essigmann J. M., Green C. L., Croy R. G., Fowler K., Büchi G., Wogan G. N. Interactions of aflatoxin B1and alkylating agents with DNA: structural and functional studies. Cold Spring Harbor Sympos. Quant. Biol. 1982; 47: 327–337
   Google Scholar
• Hsu I. C., Metcalf R. A., Sun T., Welsch J. A., Wang N. J., Hams C. C. Mutational hotspot in the p53 gene in human hepatocelluar carcinomas. Nature 1991; 350: 427–428
   PubMed Web of Science ®Google Scholar
• Bressac B., Kew M., Wands W, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429–431
   PubMed Web of Science ®Google Scholar
• Fink-Gremmels. 1996, personnal communication
   Google Scholar
• Rheeder J. P., Marasas W. F. O., Thiel P. G., Sydenham E. W., Shephard G. S., van Schalkwyk D. J. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology 1992; 82(3)353–357
   Web of Science ®Google Scholar
• Yang C. S. Research on esophageal cancer in China: A review. Cancer Res. 1980; 40: 2633–2644
   PubMed Web of Science ®Google Scholar
• Chu F. S., Li G. Y. Simultaneous occurrence of fumonisin B, and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 1994; 60(3)847–852
   PubMed Web of Science ®Google Scholar
• Bezuidenhout G. C., Gelderblom W. C. A., Gorst-Allman C. P., Horak R. M., Marasas W. F. O., Spiteller G., Vleggaar R. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme. J. Chem. Soc., Chem. Commun. 1988; 743–745
   Google Scholar
• Gelderblom W. C. A., Jaskiewicz K., Marasas W. F. O., Thiel P. G., Horak R. M., Vleggaar R., Kriek N. P.J. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 1988; 54(7)1806–1811
   PubMed Web of Science ®Google Scholar
• Ross P. F., Nelson P. E., Richard J. L., Osweiler G. D., Rice L. G., Plattner R. D., Wilson T. M. Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated with equine leukoencephalomalacia and a pulmonary endema in swine. Applied Environmental Biology 1990; 56: 3225–3226
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Kriek N. J., Marasas W. F. O., Thiel P. G. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1in rats. Carcinogenesis 1991; 12: 1247–1251
   PubMed Web of Science ®Google Scholar
• Lebepe-Mazur S., Bal H., Hopmans E., Murphy P., Henrich S. Fumonisin B1is fetotoxic in rats. Vet. Human Toxicol. 1995; 37(2)126–130
   PubMedGoogle Scholar
• Gelderblom W. C. A., Snyman S. D., Abel S., Lebepe-Mazur S., Smuts C. M., van der Westhuizen L., Marasas W. F. O., Victor T. C., Knasmulle R. S., Huber W. Hepatotoxic - and carcinogenecity of the fumonisins in rats: a review regarding mechanistic implications for establishing risk in humans. Fumonisins in Food, L. S. Jackson, I. W. De Vries, L. D. Bulleman. Plenum Press, New York 1996; 279–296
   Google Scholar
• Wang E., Norred W. P., Bacon C. W., Riley R. T., Merrill A. H. Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 1991; 266: 14486–14490
   PubMed Web of Science ®Google Scholar
• Merrill A. H. Cell regulation by spingosine and more complex sphingolipids. J. Bioenerg. Biomembr. 1991; 23: 83–104
   PubMed Web of Science ®Google Scholar
• Gelderblom W. C. A., Smuts C. M., Abel S., Snyman S. D., Cawood M. E., van der Westhuizen L., Swanevelder S. Effects of Fumonisin B1on Protein and Lipid Synthesis in Primary Rat Hepatocytes. Fd. Chem. Toxic 1996; 34: 361–369
   PubMed Web of Science ®Google Scholar
• Cornwell D. G., Morisaki N. FA paradoxes in the control of cell proliferation: prostaglandins, lipid peroxides and cooxidation reactions. Free Radicals in Biology VI, W. A. Proyor. Academic Press, Orlando, FL 1984; 95–148
   Google Scholar
• Gavino V. C., Miller J. S., Ikharebha S. O., Milo G. E., Maizewell D. G. Effect of polyunsaturated fatty acid and antioxidants on lipid peroxidarion in tissue cultures. J. Lipid Res. 1981; 22: 763–769
   PubMed Web of Science ®Google Scholar
• Krogh P. Mycoroxic porcine nephroparhy - a possible model for Balkan (endemic) nephropathy. Endemic nephroparhy, A. Puchlev. Balgarian Academy of Sciences, Sofia 1974; 266–270
   Google Scholar
• Krogh P., Hald B., Plestina R., Ceovic S. Balkan (endemic) nephropathy and foodborne ochratoxin A: Preliminary results and foodstuffss. Acta Pathologica Microbiologica et Immunologica Scandinavica Section B 1977; 85: 238–240
   Google Scholar
• Krogh P. Ochratoxin in foods. Mycotoxins in food, P. Krogh. Academic Press, London 1987; 97
   Google Scholar
• Szczech G. M., Carlton W. W., Tuite J., Caldwell R. Ochratoxin A toxicosis in swine. Vet. Pathol. 1973; 10: 347
   PubMed Web of Science ®Google Scholar
• Pavlovic M., Plestina R., Krogh P. Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy. Acta Pathologica Microbiologica et Immunologica Scandinavica Section B 1979; 87: 243–246
   Google Scholar
• Petkova-Bocharova T, Castegnaro M. Ochraroxin contamination of cereals in an area of high incidence of Bulkiin endemic nephropathv in Bulgaria. Food. Addit. Contam. 1985; 2: 267–270
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T., Chernozemsky I. N., Castegnaro M. Ochraroxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food. Addit. Contam. 1988; 5(3)299–301
   PubMedGoogle Scholar
• Bacha H., Maaroufi K., Achour A., Hamammi M., Ellouz F., Creppy E. E. Ochratoxins and ochratoxicoses in humans in Tunisia. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. John Libbey Eurotext Ltd. 1993; 111–121
   Google Scholar
• Krogh P., Gyrd-Hnsen N., Hald B., Larsen S., Nieken JP., Smith M., Lvanoff C., Meisner H. Renal e nzyme activities in experimental ochratoxin A-induced porcine nephropathy: D iagnostic potential of phosphaenolpytuvate carboxykinase and gamma-glutamyl transpeptidase activity. J. Toxicol. Environ. Health 1988; 23: 1
   PubMed Web of Science ®Google Scholar
• Creppy E.-E., Röschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochraroxin A and its prevention by phenylalanine. Fd Chem. Toxic 1984; 22(11)883
   PubMed Web of Science ®Google Scholar
• Omar R. F., Rahimtula A. D., Bartsch H. Role of cytochrome P-450 in Ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 1991; 6: 203–209
   PubMedGoogle Scholar
• Moore J. H., Truelove B. Ochratoxin A, inhibition of mitochondrial respiration. Science (Washington DC) 1970; 168: 1102
   PubMed Web of Science ®Google Scholar
• Meisner H., Chan S. Ochratoxin A an inhibitor of mitochondrial rransport. Biochem. 1974; 13: 2759
   Google Scholar
• Wei Y.-H., Lu C.-Y., Lin T.-N., Wei R. D. Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology 1985; 36: 119
   PubMed Web of Science ®Google Scholar
• Omar R. F., Hasinoff B. B., Mejilla F., Rahimtula A. D. Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 1990; 40(6)1183
   PubMedGoogle Scholar
• Hasinoff B. B., Rahimtula A. D., Omar R. F. NADPH-cyrochronie-P-450 reductase promoted hydroxyl radical production by the iron(III)-ochratoxin A complex. Biochemica et Biophysica Acta 1990; 1036: 78
   PubMed Web of Science ®Google Scholar
• Hansen C. E., Dueland S., Drevon C. A., Størmer F. C. Metabolism of ochratoxin A by primary cultures of rat hepatocytes. Appl. Environ. Microbiol. 1982; 43(6)1267–1271
   PubMedGoogle Scholar
• Størmer F. C., Støren O., Hansen C. E., Pederson J. I., Aasen A. J. Formation of (4R)-and (4S)-4-hydroxyochratoxin A and 10-hydroxvochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 1983; 45: 1183–1187
   PubMed Web of Science ®Google Scholar
• Størmer F. C., Hansen C. E., Pederson J. I., Hvistendahl G., Aasen A. J. Formation of (4R)- and (4S)-4-hydroxochratoxin A by liver microsomes from various species. Appl. Environ. Microbiol. 1981; 42: 1051–1056
   PubMed Web of Science ®Google Scholar
• Moroi K., Suzuki S., Kuga T., Yamazalu M., Kanisawa M. Reduction of ochratoxin A toxicity in mice treared with phenylalanine and phenobarbital. Toxicol. Lett. 1985; 25: 1–5
   PubMed Web of Science ®Google Scholar
• Stein A. F., Phillips T. D., Kubena L. F., Harvey R. B. Renal tubular secretion and readsorption as factors in ochratoxicosis: Effects of probenecid on nephrotoxicity. J. Toxicol. Environ. Health 1985; 16: 593
   PubMed Web of Science ®Google Scholar
• Beardall J. M., Miller J. D. Diseases in humans with mycotoxins as possible causes. Mycotoxins in grain; compounds other than aflatoxin, J. D. Miller, H. L. Trenholm. Eagan Press. 1994; 487–539, USAand references cited therein
   Google Scholar
• Krishnamachari K. A. V. R., Bhat R. V. Poisoning by ergoty bajra (pearl millet) in man. Indian J. Med. Res. 1976; 64(11)1624–1628
   PubMedGoogle Scholar
• Bhat R. V., Roy D. N., Tulpule P. G. The nature of alkaloids of ergoty pearl millet and its comparison with alkaloids of ergoty rye and ergoty wheat. Toxicol. Appl. Pharmacol. 1976; 36(1)11–17
   PubMedGoogle Scholar
• van Rensburg S. J., Altcnkirk B. Claviceps purpurea - Ergotism. Mycotoxins, I. F.H. Purchase. Elsevier, Amsterdam 1974; 69–96
   Google Scholar
• Pohland A. E. Mycotoxins in review. Food. Addit. Contam. 1993; 10(1)17–28
   PubMed Web of Science ®Google Scholar
• Porter J. K. Ergot alkaloids and alkaloids from other endophytes, responsible for causing toxic syndrome in cattle after eating contaminated grass. Prikl. Biokhim. Microbiol. 1993; 29(1)51–55
   PubMedGoogle Scholar
• Schneider D. J., Miles C. O., Garthwaite I., Van Halderen A., Wessels J. C., Lategan H. J. First report of field outbreaks of ergot-alkaloid toxicity in South Africa. Ondcrstepoort J. Vet. Res. 1996; 63(2)97–108
   PubMedGoogle Scholar
• Meylcr W. J. Side effects of ergotamine. Cephalalgia 1996; 16(1)5–10
   PubMedGoogle Scholar
• Arafat W., Musa M. N. Patulin-induced inhibition of protein synthesis in hepatoma tissue culture. Res. Commun. Mol. Pathol. Pharmacol. 1995; 87(2)177–186
   PubMedGoogle Scholar
• Grove J. F. Non-macrocyclic trichothecenes. Natural Products Report 1988; S187–209
   Google Scholar
• Grove J. F. Non-macrocyclic trichothecenes, Part 2. Prog. Chem. Org. Nat. Prod. 1997; 69: 1–70, and references cited therein
   Google Scholar
• van Egmond H. P. Aflatoxin M1: occurrence, toxicity. Regulation. Mycotoxins in Dairy Products, H. P. van Egmond. Elsevier Science Publishers LTD., England 1989; 11–55
   Google Scholar
• Meloche J. L., Smith T. K. Altered tissue amino acid metabolism in acute T-2 toxicosis. Proc. Soc. Exp. Biol. Med. 1995; 210(3)260–265
   PubMedGoogle Scholar
• Joffe A. Z. Fusarium poae and F. sporotrichioides as principal causal agents of alimentary toxic aleukia. Mycotoxic fungi, mycotoxins, mycotoxicoses - an encyclopedic handbook. Marcel Dekker, New York 1978; vol. 3: 21–86
   Google Scholar
• Williams P. P. Effects of T-2 mycotoxiri on gastrointestinal tissues: a review of in vivo and in vitro models. Arch. Environ. Contam. Toxicol. 1989; 18(3)374–387
   PubMedGoogle Scholar
• Lafarge-Frayssinet C., Decloitre F., Mousset S., Martin M., Frayssinet C. Induction of DNA single strand-breaks by T2-toxin. a trichothecene metabolite of Fusarium. Effect on lymphoid organs and liver. Mutat. Res. 1981; 88(2)115–123
   PubMed Web of Science ®Google Scholar
• Stob M., Baldwin R. S., Tuite J., Andrews F. N., Gilette K. G. Isolation of an anabolic uterotropic compound from corn infected with Gibberella zeae. Nature (London) 1962; 196: 1318
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A., Chekir-Ghedira L., Bacha H. Genotoxicity of zearalenone. an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. Carcinogenesis 1995; 16(10)2315–2320
   PubMedGoogle Scholar
• Riley R. T., Goeger D. E., Yoo H., Showker J. L. Comparison of three tetrameric acids and their ability to alter membrane function in cultured skeletal muscle cells and sarcoplasmic reticulum vesicles. Toxicology and Applied Pharmacology 1992; 114: 261–267
   PubMedGoogle Scholar
• Porter J. K., Norred W. P., Cole R. J., Dorner J. W. Neurochemical effects of cyclopiazonic acid in chickens. Proc. Soc. Exp. Biol. Med. 1988; 187: 335–340
   PubMed Web of Science ®Google Scholar
• Agarwal S. S., Phadke S. R., Fredlund V., Viljoen D., Beighton P. Mseleni and Handigodu familial esteoarrhropathies: syndromic identity?. Am. J. Med. Genet. 1997; 72(4)435–439
   PubMedGoogle Scholar
• Viljoen D., Fredlund V., Rarnesar R., Bieghton P. Brachydacrylous dwarfs of Mseleni. Am. J. Med. Genet. 1993; 46(6)636–640
   PubMedGoogle Scholar
• Ballo R., Viljoen D., Machado M., Keene D., Horton W., Fredlund V., Jacobs M., Martell R., Beighton P., Rarnesar R. Mseleni joint disease - a molecular genetic approach to defining the aetiologv. S. Afr. Med. J. 1996; 86(8)956–958
   PubMedGoogle Scholar
• Sokoloff L. Acquired chondronecrosis. Ann. Rheum. Dis. 1990; 11(2)262–264
   Google Scholar
• Zhai S. S., Kimbrough R. D., Meng B., Han J. Y., LeVois M., Hou X., Yin X. N. Kashin-Beck disease a cross-sectional study in seven villages in the People's Republic of China. J. Toxicol. Environ. Health 1990; 30(4)239–259
   PubMed Web of Science ®Google Scholar